30 closest matches · ranked by relevance
Essential Fatty Acid Deficiency (EFAD)
Primary: Number of Participants to Develop Essential Fatty Acid Deficiency (EFAD) Defined by Holman Index > 0.4 — 0; 0 Participants
Retinopathy of Prematurity · Neonatal Cholestasis
Primary: Number of Participants With Retinopathy of Prematurity — 2; 13 participants
Retinopathy of Prematurity
Primary: Changes in mRNA Expression in Blood of STAT3, PPAR-ɣ, and STC-1 at T0 — 4.19; 7.58; 6.43; 11.32 delta Ct (amplification cycles) — p=0.22
Premature, Extremely Low Birth Weight Infants · Polyunsaturated Fatty Acid Levels
Primary: Long-chain Polyunsaturated Fatty Acid (LCPUFA) Levels — 4.45; 4.02; 5.27; 20.3 weight % (g/100g)
Prematurity
Primary: Days to Reach Full Enteral Feedings and Days on Study Oil. — 20.00; 16.21; 34.00; 33.71 days — p=0.07
Attention Deficit Hyperactivity Disorder (ADHD) · Deficient Emotional Self-Regulation (DESR)
Primary: Mean Change From Baseline to Endpoint on the BRIEF-A Emotional Control Scale — -7; -33 T-Score
Adolescent Depression
Primary: Children's Depressive Rating Scale - Revised (CDRS-R) — 50.2; 49.5; 35.2; 36.5 units on a scale
Fatty Liver
Primary: Number of Participants With Improvement of >= 2 Points in NAFLD Activity Score (NAS) — 8; 9 Participants
Dry Eye
Primary: Subjective Ocular Symptoms — 27.42; 27.43 score on a scale
Major Depressive Disorder
Primary: Score on a Depression Severity Rating Scale Over Eight Weeks — -10.34; -9.26; -9.49 units on a scale
Parenteral Nutrition Associated Liver Disease
Primary: Number of Participants With Resolution of the Direct Hyperbilirubinemia — 29 Participants
Muscular Dystrophy, Duchenne
Primary: Body Composition (Body Fat) — 172.1; 232.7; 180.2; 274.8 g/Kg of body weight — p=<0.05
Muscle Protein Synthesis · Whole-body Protein Balance
Primary: Postprandial, Resting Muscle Protein Synthesis Rates — 0.055; 0.061 percent per hour
Parenteral Nutrition-related Hepatitis
Primary: Disease Progression as Measured by Serum Levels of Hepatic Enzymes
Major Depressive Disorder · Overweight · Inflammation
Primary: Percent Change in Plasma Concentration of Inflammatory Biomarkers IL-6 (pg/mL) and PBMC TNF-α (pg/mL) — 1.92; -1.27; 7.19; 4.45 percentage of change in plasma levels…
Autism Spectrum Disorder
Primary: Pervasive Developmental Disorder Behavior Inventory (PDDBI) - Autism Composite — 115.5; 106.5; 98.1; 91.4 raw score on a scale
Non-Alcoholic Fatty Liver Disease · Non-Alcoholic Fatty Liver · Non-Alcoholic Steatohepatitis
Primary: Change in Hepatic Fat Fraction [%] Between of Vitamin E and DHA EE vs Placebo — -6.8; -8.2 Percentage of liver fat
Alcohol Dependence
Primary: "Drinking Days" in the Previous Month — 19.54; 15.18; 17.75; 22.11 Days — p=<0.001
Attention Deficit Hyperactivity Disorder · Deficient Emotional Self-Regulation
Primary: Emotional Control Subscale of the Behavior Rating Inventory of Executive Function - Parent Form (BRIEF-Parent) — 65.3; 58.4 units on a scale
Alzheimer's Disease
Primary: Regional Cerebral Blood Flow Using Arterial Spin-labeling MRI — 55.7; 54.5 mL/g/min — p=0.17
Non-Alcoholic Fatty Liver Disease
Primary: Participants With Normalized Liver Enzyme Levels — 0; 0 Participants
Atopic Dermatitis · Atopic Disorders · Eczema
Primary: Provider-diagnosed Atopic Dermatitis — 217.7; 268.5 Participants with imputed values — p=0.019
Schizophrenia · Schizoaffective Disorder · Major Depression
Primary: Plasma Levels of Triglycerides and Lipoprotein Cholesterol — 155; 182; 12.68; 16.92 mg/dL
Major Depressive Disorder
Primary: Mood Symptoms Ratings — 33.0; 33.1 CDRS-R score
Attention · Memory · Mood
Primary: Simple Reaction Time (Attention) — 287.7 ms
Weight Gain · Healthy Subjects · Obesity
Primary: Proportion of n-6 HUFA in Total HUFA (%n-6 in HUFA) — 80.0; 81.3; 80.5 Percentage of total HUFA
Metabolic Syndrome
Primary: Interleukin-6 (IL-6) — 0.96; 1.01; 0.99 pg/mL — p=0.33
Focus: Nutritional Requirements for Infants
Primary: Number of Antigen-presenting B Cells — 21.9; 22.8; 25.1 percentage of CD20+ B cells
Extracellular Vesicles; Generation and Function
Primary: Numbers of Circulating Total EVs in Platelet-free Plasma (PFP) Detected by Nanoparticle Tracking Analysis (NTA) — -2.9*10^10; 7.5*10^9 vesicles per ml blood — p=<0.001
Familial Adenomatous Polyposis Coli · FAP
Primary: Absolute Change in the Number of Polyps Measured in a Focal Area of the Rectum. — -0.5; 0.5 Change from baseline number of polyps. — p=0.005